Understanding Non-Hodgkin's Lymphoma - Sarah Cannon
Dr. John Hainsworth of the Sarah Cannon Research Institute explains the different types of non-Hodgkin's lymphoma.
Author: SarahCannon
Added: 09/17/2015 (Source: Oncology Tube)
Source: Oncology Tube - September 17, 2015 Category: Cancer & Oncology Source Type: podcasts
Can Calcium Values Help Diagnose Non-Hodgkin Lymphoma?
Dr. Susan Leclair discusses calcium values and its role in diagnosing non-Hodgkin's lymphoma? Leclair unpacks the function of calcium in the body. She explains that it’s needed to control the way cell...
Author: patientpower
Added: 08/07/2015 (Source: Oncology Tube)
Source: Oncology Tube - August 7, 2015 Category: Cancer & Oncology Source Type: podcasts
ASCO 2015: Obinutuzumab Doubles Remission Duration in Patients With Relapsed, Indolent Non-Hodgkin Lymphoma
Interim analysis of a phase III study finds that adding the new anti-CD20 monoclonal antibody obinutuzumab to standard bendamustine chemotherapy significantly delays progression of indolent non-Hodgki...
Author: EMJ
Added: 06/03/2015 (Source: Oncology Tube)
Source: Oncology Tube - June 3, 2015 Category: Cancer & Oncology Source Type: podcasts
What to Expect in Hematologic Malignancies
Dr Bruce Cheson previews the most important trials being presented at ASCO 2015 on Hodgkin's and non-Hodgkin's lymphoma, acute and chronic leukemia, and multiple myeloma. (Source: Medscape Oncology)
Source: Medscape Oncology - May 22, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Novel biologic agent, lenalidomide, for treating diffuse large B-cell lymphoma
Multiple novel biologic therapies are undergoing investigation for the treatment of non-Hodgkin lymphoma. At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Martin Dreyling (Ludwig-...
Author: VJHemOnc
Added: 05/05/2015 (Source: Oncology Tube)
Source: Oncology Tube - May 5, 2015 Category: Cancer & Oncology Source Type: podcasts
Prof Martin Dreyling at ASH 2014: Novel biologic therapies for non-Hodgkin lymphoma
At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Martin Dreyling (Ludwig-Maximilians University of Munich, Munich, Germany) discusses novel biologic therapies for the management o...
Author: EMJ
Added: 03/27/2015 (Source: Oncology Tube)
Source: Oncology Tube - March 27, 2015 Category: Cancer & Oncology Source Type: podcasts
Side Effects from New Treatments in NHL discussion with Dr. Shuo Ma
Some of the side effects that come with new agents approved for the treatment of non-Hodgkin Lymphoma.
Shuo Ma, MD, PhD, assistant professor at Northwestern University in the Robert H. Lurie Compre...
Author: onclivetv
Added: 03/11/2015 (Source: Oncology Tube)
Source: Oncology Tube - March 11, 2015 Category: Cancer & Oncology Source Type: podcasts
Dr Ian Flinn at ASH 2014: Phase I study of duvelisib in patients with relapsed/refractory indolent non-Hodgkin lymphoma
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Ian Flinn (Sarah Cannon Cancer Institute, Nashville, TN) discusses a phase I study of the novel PI3k-δ,γ inhibitor, duvelisib (IPI-1...
Author: EMJ
Added: 01/26/2015 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2015 Category: Cancer & Oncology Source Type: podcasts
ASH Coverage: Hodgkin and Non-Hodgkin Lymphoma Research and Treatment News
During the 2014 American Society of Hematology (ASH) annual meeting, Dr. Ajay Gopal from Seattle Cancer Care Alliance joined Patient Power to share exciting treatment news for lymphomas. He provided a...
Author: patientpower
Added: 12/17/2014 (Source: Oncology Tube)
Source: Oncology Tube - December 18, 2014 Category: Cancer & Oncology Source Type: podcasts
Advances in Treating Diffuse Large-B-Cell Lymphoma
Diffuse large B-cell lymphoma is the most common type of non-Hodgkin lymphoma and it can be aggressive. Drs. John Gribben and Wyndham Wilson discuss new research shows promise for many.
Get email a...
Author: patientpower
Added: 10/13/2014 (Source: Oncology Tube)
Source: Oncology Tube - October 14, 2014 Category: Cancer & Oncology Source Type: podcasts
12th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2014: day 2 meeting highlights
Prof John Gribben (Barts Cancer Institute, London, UK) chairs a discussion with Dr Wyndham Wilson (National Cancer Institute, Bethesda, USA), Prof Anton Hagenbeek (Academic Medical Center, Amsterdam, ...
Author: EMJ
Added: 10/13/2014 (Source: Oncology Tube)
Source: Oncology Tube - October 13, 2014 Category: Cancer & Oncology Source Type: podcasts
12th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2014: day 1 meeting highlights
Prof John Gribben (Barts Cancer Institute, London, UK) chairs a discussion with Prof Randy Gascoyne (British Columbia Cancer Agency, Vancouver, Canada), Dr Wyndham Wilson (National Cancer Institute, B...
Author: EMJ
Added: 10/13/2014 (Source: Oncology Tube)
Source: Oncology Tube - October 13, 2014 Category: Cancer & Oncology Source Type: podcasts
New Studies for Patient with Relapsed, CD30-Positive Lymphoma
Recorded at the 2014 International Workshop on Non-Hodgkin Lymphoma, Dr. Owen O’Connor gives an update on brentuximab vedotin (Adcetris), an antibody drug conjugate (ADC) approved for the treatment of...
Author: patientpower
Added: 09/26/2014 (Source: Oncology Tube)
Source: Oncology Tube - September 26, 2014 Category: Cancer & Oncology Source Type: podcasts
Learn the Signs and Symptoms of Follicular Lymphoma (FL)
How can you tell if you might have Follicular Lymphoma (FL), a common type of indolent non-Hodgkin lymphoma (NHL). Learn the signs and symptoms from Dr. Wyndham Wilson from the National Cancer Institu...
Author: patientpower
Added: 09/22/2014 (Source: Oncology Tube)
Source: Oncology Tube - September 22, 2014 Category: Cancer & Oncology Source Type: podcasts
Watch and Wait in the Age of Continuous, Long-Term Therapy for Lymphoma: Is It Still Worth It?
Doctors and patients alike have shown excitement over a new generation of novel agents for the treatment of non-Hodgkin lymphoma that allows some patients to take continuous, oral medications with les...
Author: patientpower
Added: 09/18/2014 (Source: Oncology Tube)
Source: Oncology Tube - September 18, 2014 Category: Cancer & Oncology Source Type: podcasts
